Forian Inc. to Announce Fourth Quarter and Full Year 2021
NEWTOWN, Pa., March 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Forian Inc. (Nasdaq: FORA), a provider of software, data and analytics services to the healthcare and cannabis industries, will announce its financing results for the fourth quarter and year ended December 31, 2021 Thursday, March 24, 2022 after market close. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 24, 2022 to discuss the results.
To access the conference call, from within the United States, dial (855) 940-5323 or for international calls, dial (929) 517-0423 and enter conference ID 1275289. The webcast will be available in live at https://edge.media-server .com/mmc/p/7q8gypu2. This information is also available on our website at www.forian.com/investors. The publication of the results as well as a replay of the call immediately after its conclusion will be available on the same site.
Highlights from Forian 2021 that will be discussed on the call include:
- Acceleration of organic revenue growth since the launch of the Company’s information products in the healthcare market with more than 20 new customers acquired in 2021 and increasing sales momentum from 2022;
- Leading market share positions in Seed-to-Sale and Track and Trace technologies resulting from the business combination with Helix Technologies completed on March 2, 2021;
- Several new government contracts and renewals for the company’s government solutions; and
- Continued long-term investments in new, differentiated product offerings for the healthcare and cannabis markets.
Forian provides a unique suite of SaaS solutions, data management capabilities and proprietary data and analytics to optimize and measure operational, clinical and financial performance for customers in traditional and emerging life science segments, payers and providers healthcare providers, as well as cannabis dispensaries, manufacturers, growers and regulators. For more information, please visit the Company’s website at www.forian.com.
Cautions Regarding Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often relate to expected future business and financial performance and financial condition, and often contain words such as “expect”, “anticipate”, “intend”, ” plan”, “believe”, “seek”, “see”, “will”, “want”, “target”, similar expressions and variations or negatives of these words. Forward-looking statements, by their nature, address matters that involve risks and uncertainties, many of which are beyond Forian’s control, and are not guarantees of future results, such as statements about the anticipated benefits of the business combination involving Forian, Medical Outcomes Research Analytics, LLC and Helix Technologies, Inc., future financial and operating results, corporate strategy and anticipated product offerings and market positioning. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in the forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, accordingly, you should not place undue reliance on such statements and should exercise caution when you rely on forward-looking statements. Factors that could cause actual results to vary include, but are not limited to, risks and uncertainties associated with: the impact of the COVID-19 pandemic on Forian’s business, operations, strategy and objectives; Forian’s ability to execute its strategy; the timing of the introduction of new product offerings; and additional risks and uncertainties discussed in greater detail under “Risk Factors” in Forian’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the SEC on March 31, 2021. , and elsewhere in Forian’s SEC filings and reports. The forward-looking statements contained in this announcement are made as of the date hereof, and Forian undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. , unless necessary. under applicable law.
Media and investor contact: